Physician profile
Jamie Spence
NPI 1861845190
$3,274.03
in general payments reported to CMS, 2019-2025
29 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $702 · 2022: $526 · 2023: $538 · 2024: $1,064 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,840.33 |
| Travel and Lodging | $205.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $730.77 | 2021-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $530.48 | 2021-2024 | Intracept |
| Vertos Medical, INC. | $342.24 | 2021-2022 | |
| Spinal Simplicity, LLC | $194.89 | 2021-2023 | Ha Minuteman G3-R |
| Nevro Corp. | $194.64 | 2021-2024 | Senza |
| Averitas Pharma INC. | $153.45 | 2023-2025 | Qutenza |
| Abbvie INC. | $147.03 | 2022-2025 | |
| Grt US Holding, INC. | $122.39 | 2021-2022 | |
| Spr Therapeutics, INC | $119.39 | 2021-2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $95.89 | 2024-2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $74.79 | 2022-2025 | Exparel, Zilretta, Iovera |
| Collegium Pharmaceutical, INC. | $72.42 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $68.14 | 2025 | |
| Virtus Pharmaceuticals LLC | $58.28 | 2021 | |
| Amgen INC. | $53.10 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $38.53 | 2025 | Tonmya |
| Stryker Corporation | $35.23 | 2022 | |
| Bioventus LLC | $35.07 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Relievant Medsystems, INC. | $34.37 | 2022 | |
| Nalu Medical, INC. | $21.57 | 2022 | |
| Globus Medical, INC. | $21.50 | 2025 | Senza |
| Organogenesis INC. | $21.49 | 2024 | |
| Dexcom, INC. | $19.25 | 2024 | Dexcom G6 Transmitter |
| Ferring Pharmaceuticals INC. | $18.11 | 2024 | Euflexxa |
| Scilex Pharmaceuticals INC. | $16.39 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.91 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.06 | 2023 | Horizant |
| Allergan, INC. | $12.91 | 2021 | |
| Medtronic, INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.